Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.
Sevcenco S, Mathieu R, Baltzer P, Klatte T, Fajkovic H, Seitz C, Karakiewicz PI, Rouprêt M, Rink M, Kluth L, Trinh QD, Loidl W, Briganti A, Scherr DS, Shariat SF. Sevcenco S, et al. Among authors: fajkovic h. Prostate Cancer Prostatic Dis. 2016 Jun;19(2):163-7. doi: 10.1038/pcan.2015.60. Epub 2016 Jan 26. Prostate Cancer Prostatic Dis. 2016. PMID: 26810014
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M, Xylinas E, Kluth L, Trinh QD, Lee RK, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Kautzky-Willer A, Bachmann A, Shariat SF; UTUC Collaboration. Rieken M, et al. Among authors: fajkovic h. Eur J Surg Oncol. 2014 Jan;40(1):113-20. doi: 10.1016/j.ejso.2013.09.016. Epub 2013 Sep 20. Eur J Surg Oncol. 2014. PMID: 24113620
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF; UTUC Collaboration. Rieken M, et al. Among authors: fajkovic h. Eur J Surg Oncol. 2014 Dec;40(12):1693-9. doi: 10.1016/j.ejso.2014.03.018. Epub 2014 Apr 13. Eur J Surg Oncol. 2014. PMID: 24780094
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Seitz C, Sun M, Karakiewicz PI, Schramek P, Herman MP, Becker A, Hansen J, Ehdaie B, Loidl W, Pummer K, Lee RK, Lotan Y, Scherr DS, Seiler D, Ahyai SA, Chun FK, Graefen M, Tewari A, Nonis A, Bachmann A, Montorsi F, Gönen M, Briganti A, Shariat SF. Kluth LA, et al. Among authors: fajkovic h. Br J Cancer. 2014 Jul 15;111(2):213-9. doi: 10.1038/bjc.2014.311. Epub 2014 Jul 8. Br J Cancer. 2014. PMID: 25003663 Free PMC article.
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Rieken M, Kluth LA, Xylinas E, Seitz C, Fajkovic H, Karakiewicz PI, Lotan Y, Briganti A, Loidl W, Faison T, Crivelli JJ, Scherr DS, Bachmann A, Tewari AK, Kautzky-Willer A, Pummer K, Shariat SF. Rieken M, et al. Among authors: fajkovic h. Prostate Cancer Prostatic Dis. 2013 Dec;16(4):367-71. doi: 10.1038/pcan.2013.31. Epub 2013 Sep 3. Prostate Cancer Prostatic Dis. 2013. PMID: 23999669
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making.
Grubmüller B, Baltzer P, D'Andrea D, Korn S, Haug AR, Hacker M, Grubmüller KH, Goldner GM, Wadsak W, Pfaff S, Babich J, Seitz C, Fajkovic H, Susani M, Mazal P, Kramer G, Shariat SF, Hartenbach M. Grubmüller B, et al. Among authors: fajkovic h. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):235-242. doi: 10.1007/s00259-017-3858-2. Epub 2017 Oct 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29075832 Free PMC article.
Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis.
Aydh A, Motlagh RS, Abufaraj M, Mori K, Katayama S, Grossmann N, Rajwa P, Mostafai H, Laukhtina E, Pradere B, Quhal F, Schuettfort VM, Briganti A, Karakiewicz PI, Fajkovic H, Shariat SF. Aydh A, et al. Among authors: fajkovic h. Arab J Urol. 2022 Mar 30;20(2):71-80. doi: 10.1080/2090598X.2022.2026010. eCollection 2022. Arab J Urol. 2022. PMID: 35530569 Free PMC article. Review.
Dual immune checkpoint inhibition in metastatic renal cell carcinoma: Editorial re.: Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced RCC: extended 4-year follow-up of the phase III CheckMate 214 trial.
Schmidinger M, Shariat SF, Fajkovic H. Schmidinger M, et al. Among authors: fajkovic h. ESMO Open. 2021 Feb;6(1):100035. doi: 10.1016/j.esmoop.2020.100035. Epub 2021 Jan 7. ESMO Open. 2021. PMID: 33421736 Free PMC article. No abstract available.
153 results